Palantir (PLTR) is trading around $178, roughly $30 below its 52-week high of $207.52, and the news cycle this week has focused on a lost contract. That is the wrong place to look.

Why This Stock Now

On August 25, Motley Fool reported that Palantir’s Maven Smart System is now an official Pentagon program of record, a bureaucratic designation that sounds dry but carries real financial weight. Programs of record are generally positioned for multi-year funding in the Defense Department’s Future Years Defense Program, but “guaranteed” appropriations can still be altered by Congress. Palantir is pursuing $2.3 billion over five years to expand Maven, which identifies and analyzes battlefield data and supports AI-enabled targeting. That is a more durable funding path, not just pipeline.

The Business

Palantir builds software that turns raw institutional data into decisions, for governments and enterprises that cannot hand that data to a cloud provider’s language model. CEO Alex Karp has framed this as sovereign AI: secure, on-premise infrastructure that keeps data locked down while swapping underlying models as needed. That positioning is resonating. Q2 revenue grew 93% year-over-year to $1.94 billion, beating consensus estimates of about $1.80 billion. U.S. commercial revenue jumped 149% to $764 million. U.S. government revenue grew 90% to $809 million. GAAP net income attributable to common stockholders was about $1.06 billion.

Why Wall Street Is Paying Attention

Management raised full-year 2026 revenue guidance to $8.15-$8.158 billion, implying roughly 82% growth for the year, well above prior Street estimates near $7.73 billion. The stock surged 29.5% on the August 4 earnings day. Truist reiterated a constructive view on August 25, flagging more upside even after a 40%-plus one-month rally. Remaining deal value stood at $13.1 billion as of Q2, an 83% year-over-year increase. Gross margin was about 85% in Q2. Adjusted EBITDA margin was about 62%, and adjusted free cash flow was about $1.22 billion last quarter.

What’s Driving the Opportunity

The Maven designation is the specific catalyst that changes Palantir’s government revenue profile. It transitions the platform from experimental deployments into a standardized fixture across every military service branch, with the Army handling future contracting. Meanwhile, the AIP commercial business is expanding into enterprises that want AI decision-making without ceding control of their data to the foundation model labs. That customer base is growing, and the boot camps Palantir has used to close deals are converting at a rate that pushed U.S. commercial revenue above $764 million in a single quarter.

What Could Go Wrong

The valuation is the hardest argument to dismiss. At roughly $178, PLTR trades near 90 times trailing sales, and the business is heavily concentrated in the U.S. International government exposure carries execution risk. France’s domestic intelligence agency has reportedly been shifting work toward a local competitor, ChapsVision. The stock spent most of 2026 down sharply before August’s reversal, which means sentiment can flip fast. Peter Thiel has sold shares over time, including a large March 2026 sale under a 10b5-1 plan. Cathie Wood sold roughly $27 million of PLTR on August 21, the same day her firm disclosed a similarly sized purchase of SpaceX shares. Insider dynamics deserve attention.

The Bottom Line

The FAA contract loss that dominated headlines this week is real but modest relative to a pipeline that already carries $13.1 billion in remaining deal value. Maven becoming a program of record is not a headline event; it is a structural shift in how the U.S. military plans and funds Palantir’s platform. Combined with 93% revenue growth, a clean balance sheet with minimal debt, and commercial momentum that shows no sign of decelerating, PLTR is the most asymmetric large-cap AI software position available right now. The valuation premium is high. The growth rate justifying it is higher.